Akari Therapeutics (AKTX) Insider Trading & Ownership $1.17 +0.01 (+0.86%) As of 06/26/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics (NASDAQ:AKTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage38.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$19.12KNumber OfInsiders Selling(Last 12 Months)0 Get AKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Akari Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AKTX Insider Buying and Selling by Quarter Akari Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/24/2025Abizer GaslightwalaCEOBuy5,203$1.16$6,035.48 6/23/2025Abizer GaslightwalaCEOBuy943$1.15$1,084.45 6/20/2025Abizer GaslightwalaCEOBuy10,000$1.20$12,000.00 (Data available from 1/1/2013 forward) AKTX Insider Trading Activity - Frequently Asked Questions Who is on Akari Therapeutics' Insider Roster? The list of insiders at Akari Therapeutics includes Abizer Gaslightwala. Learn more on insiders at AKTX. What percentage of Akari Therapeutics stock is owned by insiders? 38.10% of Akari Therapeutics stock is owned by insiders. Learn more on AKTX's insider holdings. Which Akari Therapeutics insiders have been buying company stock? The following insider purchased AKTX shares in the last 24 months: Abizer Gaslightwala ($19,119.93). How much insider buying is happening at Akari Therapeutics? Insiders have purchased a total of 16,146 AKTX shares in the last 24 months for a total of $19,119.93 bought. Akari Therapeutics Key ExecutivesMs. Rachelle Suzanne Jacques (Age 53)President, CEO & Director Compensation: $632.25kMs. Wendy F. DiCicco CPA (Age 57)Interim Chief Financial Officer Compensation: $540.34kMs. Melissa Bradford-Klug (Age 54)Chief Operating Officer Dr. Miles Nunn (Age 55)Chief Scientific Officer Dr. John F. Neylan III (Age 71)M.D., Executive VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Fate Therapeutics Insider Buying Kyverna Therapeutics Insider Buying Black Diamond Therapeutics Insider Buying Vaxart Insider Buying Lexeo Therapeutics Insider Buying Lyell Immunopharma Insider Buying Neumora Therapeutics Insider Buying Nkarta Insider Buying FitLife Brands Insider Buying Caribou Biosciences Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short Squeezes This page (NASDAQ:AKTX) was last updated on 6/27/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKTX Stock Free AKTX Stock Alerts